We test for the following disease categories

Why do we believe in genetic testing?

We are dedicated to provide the complete spectrum of genetic, biochemical and biomarker analyses. Our commitment is to convert diagnostic data rapidly into the best solution for each individual patient. With the highest quality in medical interpretation, maintained by CentoMD®, the world’s largest mutation database for rare diseases, and global data sources, we continuously develop new and innovative products in molecular diagnostics.

Why choose CENTOGENE

Expert medical consultation

Advanced logistical solutions from sample sending to report administration

Global genotype-phenotype database for rare diseases CentoMD®

Shortest turnaround time and fast reporting

Diagnostic services

Whole exome sequencing

Whole exome sequencing provides information on all genes and identifies changes in DNA by focusing on the most informative regions of the genome, for a quick and cost-effective diagnostic solution.

Clinical exome sequencing

CentoDx Plus™ focuses on the coding part of all genes associated with known clinical phenotypes, thereby comprising the complete clinical exome. It´s our largest NGS panel available, covering over 3,200 diseases.

Whole genome sequencing

Whole genome sequencing is ideal for finding novel mutations and identifying atypical presentations of a disease – especially for patients that exhibit a heterogeneous or atypical phenotype.

Biomarker & biochemical testing

Biomarkers play an essential role in the diagnosis, prediction and therapy monitoring of several metabolic diseases, especially when patients have accessible treatment options.

NGS Panel Genomic

NGS Panel Genomic avoids the additional costs of step wise analysis from deletion/duplication, follow up exome or genome sequencing, mitochondrial analysis, or analysis of new genes associated with the phenotype when new information surfaces.

Non-invasive prenatal testing

CentoNIPT® offers genetic, non-invasive prenatal testing (NIPT) to screen for the most common fetal chromosomal abnormalities. Our test combines the latest next generation sequencing technology with expert medical reporting.

Hereditary cancer

Our medical and genetic experts can help determine which genetic testing is right to analyze if your patient has an increased risk for hereditary cancer.

Male and female infertility testing panel

CENTOGENE offers three different infertility genetic panels, taking into account the common genetic causes of isolated infertility.

Mitochondrial disease testing

CentoMito® helps to identify mitochondrial diseases to determine possible treatments and to suggest the best fitting therapy.

Genetic testing of newborns with CentoICU™

CENTOGENE´s comprehensive NGS panel CentoICU™ allows you to utilize one test to provide an accurate diagnosis of 806 genes and newborn-related diseases using dried blood spots - for the early and fast diagnosis of critically ill newborns & children.

Somatic mutations

Somatic mutation testing is of enormous help for survival and life-quality of cancer-affected patients and their families. Discover our oncogenetic panels and detect the most common cancer causing mutations.

Prenatal testing

Prenatal diagnosis allows for the sensitive identification of disease-causing mutations in at-risk families before birth and is offered for all diseases with congenital or early onset. Prenatal testing is given the highest priority at CENTOGENE.

CGH array

Comparative genomic hybridization is a molecular cytogenetic method for analyzing copy number variations. CGH array allows us to quickly and efficiently determine the relative abundance of nucleic acid sequences in the target sample.